Center for Cancer Care

Goshen, Indiana 46526

0 studies enrolling now · 2 studies all time

What they study most

Chronic Lymphocytic Leukemia, Multiple Myeloma, Myeloma, Plasma-Cell, PLASMACYTOMA

Studies at this site

• Phase I/II Study of hLL1 in Multiple Myeloma — Completed
• An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia — Completed